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Background: Ablation of premature ventricular contractions (PVC) can be challenging due to infrequent sponta-
neous ectopy and the limitations subjective pacemapping (PM). Activation mapping (AM) provides an objective
parameter, but relies on spontaneous ectopic activity.
Objectives: The objective of the studywas to evaluate the correlation of automated templatematching (TM)with
activation timing and to investigate potential implications towards ablation success.
Methods: Forty patients undergoing catheter ablation of idiopathic outﬂow tract VT or PVC in 47 procedureswere
included. PVC/VT origin was determined by PM and AM. A percentage value for PM was calculated using TM
software and correlated with corresponding activation timing. Overall, 126 TM and corresponding AM values
were analyzed. All patients were followed (313 ± 158 days after ablation) including a 24-hour Holter ECG.
Results: A correlation between TM and activation timing (r = 0.66, P b 0.0001) could be shown. Success rate at
followup was 77%. No statistically signiﬁcant coherence of TM percentage and relapse was observed.
Conclusions: Templatematching correlateswith activation timing in the process ofmapping idiopathic focal PVC/VT.
TM helps to objectify the process of PM andmay therefore be helpful to guide successful ablation in the absence of
spontaneous ectopy.
© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Premature ventricular contractions (PVC) or idiopathic ventricular
tachycardia (VT) in the otherwise healthy heart is not associated with
increasedmortality in the absence of a short coupling interval or a com-
promised left ventricular function and does not require treatment if
asymptomatic [1]. Symptomatic PVC or VT on the other hand can
burden patients with recurring palpitations, dizziness, dyspnea and
possibly syncope in cases of fast VT. A reversible decrease in left ventric-
ular function has been reported even in patientswith nounderlying car-
diomyopathy [2]. Radiofrequency ablation (RFA) is a well-established
method to treat idiopathic PVC and VT, and is associated with satisfying
long-term results [3]. Determination of the ideal ablation site during thersity Heart Center, University
, University Hospital Cologne,
49 221 47832712.
of Electrophysiology, University
iversity Hospital Bern, Bern,
land Ltd. This is an open access articlelectrophysiological study is commonly achieved by PM and AM. How-
ever, AM depends on frequent spontaneous PVC/VT during the electro-
physiological study. In case of infrequent spontaneous activity it is
common practice to administer isoproterenol to facilitate spontaneous
ectopic activity, which has been shown to potentially alter the
accuracy of AM [4]. An automated waveform comparison algorithm is
implemented in the Bard® LabSystem™ PRO software (C.R. Bard, Inc.
Lowell, MA), allowing fast online matching during electrophysiological
study. Yet, correlation of this automated quantitative comparison of
paced and spontaneous morphology and corresponding activation
timing has not been studied. In addition, followup of patients to evalu-
ate success of ablation and a possible correlation with template
matching percentage has not been looked into so far. The purpose of
this studywas to investigate a possible correlation between 1) the auto-
mated template matching percentage and the activation timing during
spontaneous PVC/VT, as well as between 2) the automated template
matching percentage and the acute and late outcomes after ablation.
2. Material and methods
A retrospective analysis of 47 procedures of 40 consecutive patients
undergoing catheter ablation for idiopathic VT or PVC from the right ore under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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and May of 2010 was undertaken.
2.1. Electrophysiological study and radiofrequency ablation
Electrophysiological study (EP) was performed in the fasting state
and under sedation with propofol, after informed written consent was
obtained. All patients had discontinued betablocker and antiarrhythmic
medication for at least ﬁve half-lives and for feasibility reasons only pa-
tients with frequent PVC at the time of EP study were included. The
source of ectopy was determined by both AM and conventional PM
(1 mV above pacing threshold at 1.0 ms pulse duration). PM and AM
were assessed for each catheter site if sufﬁcient spontaneous PVC were
present, before the catheter was moved to the next mapping site. PM
was performed at a pacing cycle length within ±100 ms of the coupling
interval of the clinical PVC or at the same cycle length as the clinical VT
[5]. Irrigated RF energy was delivered with a maximum power of 38 W
for up to 180 s. A 7 French deﬂectable catheter with a 3.5-mmdistal elec-
trode (Thermocool, Biosense-Webster, Diamond Bar, CA, USA) was used
for mapping and ablation. Successful ablation site was determined as the
catheter position in which delivery of RF energy resulted in cessation of
the spontaneousVT/PVCwithout recurrence throughout awaitingperiod
of 30 min. Unsuccessful ablation was deﬁned as an RF delivery for N30 s
at a suspected site of VT/PVC origin, after which spontaneous ectopy of
the same morphology persisted with unaltered spontaneous activity.
2.2. Template matching
Activation timing was measured from the local electrogram to the
onset of the QRS in the 12 lead ECG. When electrograms were not dis-
crete a second investigator (AS) was consulted and a consensus found
to provide the highest possible accuracy for activation timing measure-
ments. Percentage matching of the pacemap was measured with the
aforementioned TM software (Bard® LabSystem™ PRO). A template of
the clinical ectopy (dominant morphology if more than one) wasFig. 1. Representative example of templatematching scoring. Selected template of the clinical ec
correlation of 98% and 97%.created manually by positioning calipers strictly adjacent to the QRS.
Paced electrograms were also marked manually and subsequently ana-
lyzed by the software, using the normalized correlation coefﬁcient
(CORR), as described recently [6], calculating correlation for each lead
and subsequent mean of all leads (example given in Fig. 1). A mean of
three measured scores was calculated to minimize the effect of beat-
to-beat variation, with the ﬁrst paced beat excluded from analysis. For
each matching score the activation timing at this catheter location was
measured before a template matching score was acquired in order to
blind the investigator at the time of activation timing measurement.
Values were acquired at all successful and unsuccessful ablation sites.
Additional values were acquired during the process of PM, at sites
where no RF energy was delivered.2.3. Follow-up
We evaluated subjective ablation success and currentmedication by
standardized questionnaire in person or via telephone after the abla-
tion. Palpitation symptoms were assessed by questionnaire, from:
“worse”, “equal” or “better than before ablation”, to “no more symp-
toms”. Patients were asked to submit a 24-hour Holter ECG, recorded
at least 3 weeks after the ablation. Ablation success was deﬁned as free-
dom from or signiﬁcant reduction of symptomswith PVC burden of less
than 2% during follow-up. Successful VT ablation was deﬁned as free-
dom from VT and its symptoms.2.4. Statistical analysis
Continuous variables are expressed as means ±1 standard devia-
tion. Assuming a linear correlation, Pearson's correlation coefﬁcient
was used to analyze the relationship of template matching and activa-
tion timing. Student's t-test was utilized to compare continuous
variables.
A P-value (2-sided) b 0.05 was considered statistically signiﬁcant.topy on the left, with two of the three evaluated pacemap beats on the right side showing a
Fig. 2. Scatterplot of template matching scores and corresponding activation timing for
successful (•), unsuccessful (x) and non-ablation sites (o).
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Template matching correlates with the earliest activation during
PVCmapping and serves as an objective surrogate parameter of earliest
activation in the setting of little spontaneous ectopic activity.
4. Results
4.1. Study population
The study comprised 47 procedures of 40 patients undergoing cath-
eter ablation for idiopathic VT or PVC originating in the right (30) or left
(10) ventricular outﬂow tract between March of 2009 and May of 2010
(18 men, 22 women, age = 48 years ± 15, range 22–76). Sustained-VT
was observed in 4, nonsustained-VT in 4 and PVC in 39 cases. Transtho-
racic echocardiography and12 lead ECGwas available in all patients and
showed no indication of underlying structural heart disease or PVC in-
duced impairment of LV function. All patients suffered from idiopathic
VT/PVC. Additional patient characteristics are shown in Table 1.
4.2. Template matching
Overall, 126 template matching values with a corresponding activa-
tion timing in msweremeasured, of which 42were acquired at a site of
acute ablation success (at 3 sites with acute ablation success activation
timing measurement was not available due to lack of spontaneous
PVC shortly before ablation), 8 at sites with unsuccessful ablation and
76 at sites investigated in the process of PMwhere noRF energywas de-
livered due to an unsatisfying subjective PM or activation timing.
In all but 2 cases we found a matching percentage of at least 93% at
the site of acute ablation success. Because of the small number of
ablation sites classiﬁed as nonsuccessful, a cutoff percentage as well as
positive predictive valuewere not calculated. Pearson's correlation coef-
ﬁcient revealed a correlation between activation timing and percentage
pacemap (r = 0.66, P b 0.0001; Fig. 2). The mean template matching
score at unsuccessful ablation sites was 88 ± 7% and therefore signiﬁ-
cantly lower than the mean score at successful sites (95.5 ± 8% P =
0.01; Table 2). No signiﬁcant difference in template matching percent-
age or activation timing was found between left and right ventricular
outﬂow tract.
4.3. Follow-up
A total of 37 patients were evaluated for 44 procedures (6 redo pro-
cedures and one patient with ablation of 2 morphologies) by personal
follow-up (28) or via telephone (9) (313 ± 158 days after ablation.
Range 36–700 days) after ablation. A post procedural 24-hour Holter
ECG was available in all cases (237 ± 165 days. Range 24–535 days
after the procedure). Six patients with redo procedures were asked toTable 1
Characteristics of the study population. Mean and standard deviation or number and per-
centage are provided. AAD = anti arrhythmic drugs, CHD = coronary heart disease,
PVC = premature ventricular contractions, VT = ventricular tachycardia.
Age [years] 48 ± 16
Women (%) 22 (55)
Ectopy before ablation
PVC Burden % 12.9 ± 10.5
History of VT n (%) 8 (17)
Medication before procedure
Betablocker (%) 20 (43)
Class IC AAD (%) 8 (17)
Cardiovascular disease
CHD (%) 2 (5)
Hypertension (%) 15 (38)
Atrial ﬁbrillation (%) 5 (8)
Congestive heart failure 0 (0)evaluate their condition after the initial procedure, as well as their cur-
rent state. All patients previously treated with speciﬁc antiarrhythmic
medication had discontinued their class Ic medication. Eight of 19 had
stopped taking a betablocker since the ablation. In 5 of the 11 patients
who kept taking a betablocker themedicationwas continued due to an-
other coinciding indication (CAD in 1, hypertension in 4).
Ablation success at follow-up was seen in 34 of 44 cases (77%). The
mean PVC burden after ablation was 0.4 ± 0.7% in the successful abla-
tion group and 7.1 ± 6.7% in the recurrence cohort (P b 0.01). There
was a signiﬁcant reduction in PVC burden from pre to post ablation in
the unsuccessful ablation cohort from 12 ± 11.8% to 7.1 ± 6.7% (P =
0.04; t-test for paired samples). No signiﬁcant difference in pre ablation
PVC burden was observed between the successful and unsuccessful
groups. Of the 8 cases with idiopathic VT within the study cohort none
experienced recurrence of VT and 7 were free of symptoms after a
followup of 269 ± 157 days. One VT patient underwent a successful
second ablation because of symptomatic PVC with an identical mor-
phology as the previously treated VT and proved to be free of symptoms
at followup. Template matching of this patient during the initial proce-
dure was 87%.
Therewas no statistically signiﬁcant difference between the group of
patients with and without ablation success at follow-up, with regard to
template matching score and activation timing (39.6 ± 9.6 ms vs. 41 ±
10 ms and 94.4 ± 4.5% vs. 95.5 ± 2.5%; Table 3) and betablocker
medication. Three patients were lost to followup.
5. Discussion
The present study provides the following major ﬁndings: Foremost,
TM shows correlation with activation timing in our study group and
thus may serve as a surrogate objective marker and additive tool in
the setting of PVC/VT ablation in the absence of frequent spontaneous
ectopy. Secondly, a high template matching percentage predicts a suc-
cessful ablation site [6].
Successful ablation of ventricular ectopy relies on PM and AM. The
spatial resolution of AM is superior to that of PM [7]. While the results
of PM have to be interpreted by the electrophysiologist, AM provides
objective information. If measured correctly, it is acquired swiftly and
inter-observer variation should be low. Hence, predominantly relying
on AM is desirable when ablating ventricular ectopy. In the absence of
frequent spontaneous PVC/VT during the electrophysiological study,
AM cannot be carried out effectively. In this setting, no objectivemarker
Table 2
Template matching percentage and activation timing at ablation sites. Means and standard deviation provided for sites of acute ablation success and failure.
Acutely successful lesions (n = 45) Acutely unsuccessful lesions (n = 8) P-value (2-sided)
Template matching [%] 95.5 ± 8.1 88 ± 7.2 0.01
Activation timing [ms] 42.2 ± 11 22 ± 12 0.0007
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uate ablation success and prolong the procedure, especially for a less ex-
perienced operator. The administration of isoproterenol to provoke the
clinical ectopy is not consistently effective and may interfere with AM
results by widening the area of activation timing, posing the risk of a
poor outcome due to inaccurate localization of the ectopy (4). Quantita-
tive comparison between clinical ectopy and paced morphology using
mathematical waveform comparison metrics was ﬁrst described by
Gerstenfeld in 2003. Using an ofﬂine analysis approach by correlation
coefﬁcient (CORR) and mean absolute deviation (MAD), a signiﬁcant
correlation of the similarity score and the distance from the ectopy as
well as a signiﬁcantly lower correlation score for unsuccessful ablation
sites could be demonstrated. An association with successful ablation
sites was only demonstrated for MAD [8]. Since then, an automated
waveform comparison algorithm using CORR has been implemented
in the Bard® LabSystem™ PRO Software.
In a study byKurosaki et al. [6] TMwas shown to be a better discrim-
inator than subjective scoring by an experienced electrophysiologist,
using ROC analysis. A TM correlation of≥90% predicted a successful ab-
lation site with a sensitivity of 90%. Our ﬁndings are consistent with the
latter observation. Published detailed data on follow-up after ablation of
idiopathic PVC is sparse. Darrieux et al. reported immediate success in
23/30 cases (77%) and a long-term success in 19/23 patients (83%)
after a median followup of 14.5 ± 5 months, deﬁning success as a
≥90% reduction of PVC/24 h in pre- to post ablation Holter ECG and
freedom from symptoms. At least three 24 h Holter ECGwere evaluated
at followup, showing a range of 246–2020 PVC/h in the relapse group
and a range of 0–166 PVC/h in the success group [9]. Krittayaphong
et al. reported acute success in 32/33 patients (97%) and a recurrence
of ≥1000 PVC/24 h in 8/32 (25%) cases at 1 month followup. Of these
eight patients, three reported minimal symptoms and did not undergo
another ablation [10]. The success rate in our study population was
comparable to that of Krittayaphong et al., butwas seen at a substantial-
ly longer followup.While the deﬁnition of N1000 PVC/24 h seemsmore
restrictive than the one we used, only one patient (1669 PVC/24 h =
1.6%) in our collective, who was completely free from symptoms,
would have been rated as a late ablation failure. Our deﬁnition is also
considerably more restrictive than recently reported criteria of 80%
PVC burden reduction [11]. There is no consensus or uniform deﬁnition
on late or long-term ablation success after PVC ablation. We therefore
chose a combined endpoint, primarily symptom oriented, since the
indication for ablation of PVC is also almost exclusively based on
symptoms.
The present study revealed no difference in outcome with regard to
PM percentages. Several reasons should be considered. A marginally
suboptimal ablation position as a causemay not be adequately reﬂected
by the small number of relapse in this study population to provide a sta-
tistically signiﬁcant difference in templatematching. Possibly, while the
site of ablation determines acute success, late outcome may depend on
additional determinants such as lesion maturation and -depth and un-
known factors leading to recovery of ectopic activity. Data on late and
long-term recurrence after initially successful ablation of idiopathic VTTable 3
Template matching percentage and activation timing for the group with and without recurren
No recurrence (n = 34)
Template matching [%] 95.5 ± 2.5
Activation timing [ms] 41 ± 10shows a range from 30/58 (52%) after long-term followup of 135 ±
68 months to around 11/27 (37%) after 34 ± 11 months [12]. More
than half of the patients with long-term recurrence in the latter study
presented with a new VT morphology. In our study the small group
ofpatients with VT consisted of 8 patients, of those all but one were
free of symptoms after single ablation procedure. The one patient
complaining of palpitations experienced a recurrence of symptomatic
PVC. He was successfully treated in a second procedure and was free
of symptoms at followup. Template matching in this patient's initial
procedure was only 87%.
AM remains the gold standard in PVC and VT ablation. In situations
where AM is not conveniently applicable, TM may serve as a surrogate
objective marker as it correlates with activation timing and might im-
prove ablation success in the long run. It is conceivable that high tem-
plate matching percentage in general may lead to better outcomes in
these patients if greater patient populations are taken into account.
Therefore, the present results give a strong indication towards prospec-
tive evaluation.
5.1. Study limitations
The procedures were analyzed retrospectively. In addition, the in-
vestigators were not blinded at the time of analysis with regard to
acute ablation success but activation timing was measured before tem-
plate matching percentage was acquired to prevent possible bias. To
evaluate outcome after ablation, all patients received a Holter ECG.
Due to day to day variability, a single Holter ECG may not accurately
represent the true PVC burden after ablation. This limitation affects all
included patients, limiting its bias. Three patients were lost to followup.
6. Conclusions
Automated template matching accurately predicts acute ablation
success and correlates with activation timing. It therefore could facili-
tate the process ofmapping and ablation in the setting of only occasion-
al ventricular ectopic activity.
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